Home > Drug Search >
  • company_query: Affectis Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (32) biology (1)
Status:
Phase Ⅲ (4) Phase Ⅱ (12) Phase Ⅰ (15) IND Filing (2)
Clinical Stage:
Pending (5) Active (16) Discontinued (11)
Indication:
Acne (1) Actinic keratosis (AK) (1) Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Amyotrophic lateral sclerosis (ALS) (2) Cushing's disease (1) Fragile X syndrome (1) Gastric cancer (1) Glaucoma (1) HBV infection (1) HCV infection (1) HIV infection (1) Idiopathic pulmonary fibrosis (IPF) (1) Insomnia (1) Irritable bowel syndrome (IBS) (1) Major depressive disorder (MDD) (2) Malignancies (1) Non small cell lung cancer (NSCLC) (2) Pancreatic cancer (1) Parkinson's disease (PD) (2) Peripheral  neuropathy (1) Prostate cancer (1) Psoriasis (1) Rheumatoid arthritis (RA) (1) Solid tumours (7) Ulcerative colitis (1) Nasopharyngeal cancer (1) Helicobacter pylori infection (1) Hematological cancer (2) Sepsis (1) Ischemic stroke (1) Esophagus cancer (1) Angelman syndrome (1) Dengue fever (3) Age-associated memory impairment (AAMI) (1) Memory impairment (1) Diabetic neuropathy (1) Liver cancer (1) Metabolic Syndrome X (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top